The Journal of Organic Chemistry
ARTICLE
removed on a rotary evaporator. The residue was purified on a grade 3
neutral alumina column, eluting initially with dichloromethane. After a
pink band had been collected, the solvent was switched to chloroform
and the product eluted as a dark-green band. Recrystallization from
chloroformꢀmethanol gave the oxybenziporphyrin (47 mg, 0.082
mmol, 45%) as a dark-purple solid, mp >300 °C; UVꢀvis (CHCl3):
λmax (log ε) 343 (4.42), 432 (5.25), 453 (4.87), 594 (4.47), 641 (3.96),
704 nm (3.82); UVꢀvis (80 equiv TFA-CHCl3): λmax (log ε) 328
(4.41), 433 (5.23), 470 (4.77) 613 (4.26), 696 nm (3.85); UVꢀvis (20%
TFA-CHCl3): λmax (log ε) 355 (4.71), 437 (4.92), 560 (3.89), 607
128.8, 132.1, 132.7, 133.4, 134.0, 135.3, 136.6, 137.1, 137.8, 138.7, 140.6,
144.6, 144.7, 154.3, 154.8, 187.3; 13C NMR (TFA-CDCl3): δ 11.7, 16.1,
17.1, 19.67, 19.71, 92.8, 93.8, 113.2, 117.3, 122.1, 123.4, 127.5, 129.0,
129.3, 131.7, 135.3, 139.0, 140.0, 140.5, 140.7, 141.4, 142.1, 143.3, 143.7,
144.9, 186.7; HR MS (EI): calcd for C36H37N3O: m/z 527.2937; found:
527.2932. Anal. Calcd for C36H37N3O.1/10CHCl3: C, 80.35; H, 6.93; N,
7.79. Found: C, 80.56; H, 6.99; N, 7.87.
9,18-Diethyl-8,19-dimethyl-13,14-diphenyl-2-oxynaphthi-
porphyrin (23b). Tripyrrane 13b6b (212 mg, 0.38 mmol) and
dialdehyde 22 (82.7 mg, 0.38 mmol) were reacted under the fore-
going conditions. Recrystallization from chloroformꢀmethanol gave
the oxynaphthiporphyrin (88 mg, 0.14 mg, 36%) as purple crystals,
mp 240 °C, dec; UVꢀvis (CHCl3): λmax (log ε) 406 (sh, 4.70), 431
(5.35), 446 (5.02), 540 (3.90), 584 (4.59), 625 (4.14), 686 nm (3.74);
UVꢀvis (80 equiv TFA-CHCl3): λmax (log ε) 324 (4.47), 435 (5.32),
462 (4.94), 553 (sh, 3.88), 578 (sh, 4.07), 603 (4.35), 622 (4.39),
675 nm (3.87); UVꢀvis (50% TFA-CHCl3): λmax (log ε) 338 (4.46),
376 (4.66), 416 (sh, 4.65), 446 (4.89), 465 (4.85), 645 (4.48), 699
(4.10), 775 nm (3.93); 1H NMR (500 MHz, CDCl3): δ ꢀ7.26 (1H, s),
ꢀ3.76 (2H, br s), 1.68 (3H, t, J = 7.7 Hz), 1.71 (3H, t, J = 7.7 Hz), 3.50
(3H, s), 3.58 (3H, s), 3.78ꢀ3.86 (4H, 2 overlapping quartets),
7.59ꢀ7.63 (2H, m), 7.67ꢀ7.71 (4H, m), 7.74 (1H, t, J = 7.5 Hz),
7.93ꢀ7.96 (4H, m), 7.95ꢀ7.99 (1H, m), 8.91 (1H, dd, J = 1.4,
7.7 Hz), 9.01 (1H, d, J = 8.2 Hz), 9.603 (1H, s), 9.605 (1H, s), 10.14
(1H, s), 10.73 (1H, s); 1H NMR (500 MHz, TFA-CDCl3): δ ꢀ5.69
(1H, s), ꢀ4.10 (1H, br s), ꢀ1.42 (1H, br s), ꢀ0.98 (1H, br s), 1.50
(3H, t, J = 7.7 Hz), 1.52 (3H, t, J = 7.7 Hz), 3.47 (6H, s), 3.82 (4H, q,
J= 7.7 Hz), 7.67ꢀ7.75 (6H, m), 7.78 (1H, t, J= 7.5 Hz), 7.90ꢀ7.94 (4H, m),
8.07ꢀ8.10 (1H, m), 8.81 (1H, dd, J = 1.3, 7.8 Hz), 8.96 (1H, d, J = 8.1 Hz),
9.80 (1H, s), 9.86 (1H, s), 10.60 (1H, s), 10.88 (1H, s);13C NMR (CDCl3):
δ 12.0, 17.06, 17.11, 19.6, 98.0, 98.5, 103.0, 104.8, 113.4, 121.1, 123.5, 125.1,
127.5, 128.0, 128.7, 128.8, 132.5, 132.7, 133.0, 133.9, 135.6, 136.3, 137.3,
137.7, 137.9, 138.1, 138.7, 140.5, 144.5, 144.6, 152.9, 153.4, 187.5; 13C NMR
(TFA-CDCl3): δ 12.0, 12.1, 16.3, 19.9, 95.6, 96.8, 111.2, 111.7, 120.1, 124.4,
127.6, 129.27, 129.29, 129.39, 129.40, 132.29, 132.34, 132.73, 132.77, 133.0,
135.0, 137.4, 138.2, 138.3, 139.4, 139.5, 140.0, 140.1, 140.5, 140.8, 141.0,
141.2, 142.5, 190.0; HR MS (EI): Calcd for C44H37N3O: 623.2937. Found:
623.2921. Anal. Calcd for C44H37N3O.1/20CHCl3: C, 84.01; H, 5.93; N, 6.67.
Found: C, 84.01; H, 5.93; N, 6.62.
[9,13,14,18-Tetraethyl-8,19-dimethyl-2-oxybenzipor-
phyrinato]silver(III) (26a). A suspension of silver(I) acetate (40 mg)
in methanol (10 mL) was added to a solution of 9,13,14,18-tetraethyl-8,19-
dimethyl-2-oxybenziporphyrin (17a, 20.0 mg) in chloroform (20 mL) and
the resulting mixture stirred at room temperature for 16 h. The mixture was
washed with water and evaporated under reduced pressure. The residue was
purified by column chromatography on grade 3 alumina, eluting with
chloroform and then 1% methanol-chloroform. Evaporation of the green
fractions afforded a dark residue. Recrystallization from chloroformꢀ
methanol gave the silver derivative (23.5 mg, 96%) as a dark-purple powder,
mp >300 °C; IR (KBr): ν 1641 (s), 1619 cmꢀ1 (s, CdO str.); UVꢀvis
(CHCl3): λmax (log ε) 336 (4.51), 456 (4.94), 524 (3.55), 608 (4.40),
629 nm (4.20); 1H NMR (400 MHz, CDCl3): δ 1.60 (3H, t, J = 8 Hz),
1.64ꢀ1.73 (9H, 3 overlapping triplets), 3.10 (3H, s), 3.31 (3H, s), 3.62
(2H, q, J = 8 Hz), 3.67ꢀ3.75 (6H, 3 overlapping quartets), 7.32 (1H, d, J =
8.4 Hz), 8.44 (1H, d, J = 8.4 Hz), 8.69 (1H, s), 9.01 (1H, s), 9.13 (1H, s),
10.23 (1H, s); HRMS (EI): calcd for C32H32N3OAg: 581.1610; found:
581.1608. Anal. Calcd for C32H32N3OAg.1/8CHCl3: C, 64.51; H, 5.37; N,
7.02. Found: C, 64.56; H, 5.38; N, 6.95.
1
(4.29), 707 (3.88), 778 nm (4.04); H NMR (500 MHz, CDCl3):
δ ꢀ7.27 (1H, br d, J = 2.0 Hz), ꢀ3.67 (2H, br s), 1.62ꢀ1.68 (6H,
2 overlapping triplets), 3.30 (3H, s), 3.45 (3H, s), 3.68ꢀ3.75 (4H,
2 overlapping quartets), 7.27 (1H, d, J = 9.4 Hz), 7.59ꢀ7.63 (2H, m),
7.69 (4H, t, J = 7.5 Hz), 7.89ꢀ7.92 (4H, m), 8.42 (1H, dd, J = 2.0, 9.4
Hz), 8.91 (1H, s), 9.37 (1H, s), 9.41 (1H, s), 10.25 (1H, s); 1H NMR
(500 MHz, TFA-CDCl3): δ 1.32ꢀ1.36 (6H, 2 overlapping triplets),
2.96 (3H, s), 2.97 (3H, s), 3.15ꢀ3.20 (4H, 2 overlapping quartets), 5.29
(1H, s), 5.48 (1H, br s), 5.51 (1H, br s), 7.54ꢀ7.57 (4H, m), 7.58ꢀ7.62
(7H, m), 8.09 (1H, s), 8.13 (1H, s), 8.61 (1H, dd, J = 1.8, 8.7 Hz), 8.87
(1H, s), 9.47 (1H, s); 13C NMR (CDCl3): δ 11.5, 11.8, 16.9, 17.0, 19.39,
19.43, 97.2, 99.1, 105.5, 110.9, 111.9, 122.0, 126.3, 127.61, 127.62, 128.7,
130.3, 132.2, 132,4, 134.5, 135.5, 136.0, 137.4, 138.01, 138.03, 138.2,
140.1, 144.7, 145.2, 147.0, 153.5, 154.8, 187.9; 13C NMR (TFA-
CDCl3): δ 11.2, 14.9, 15.0, 18.8, 96.8, 98.0, 120.0, 120.5, 122.0, 124.4,
127.7, 129.6, 130.29, 130.32, 130.35, 131.0, 141.2, 141.8, 141.9, 142.2,
143.6, 144.1, 147.4, 148.3, 148.5, 149.3, 149.6, 155.3, 156.8, 171.2; HR
MS (FAB): calcd for C40H35N3O þ H: m/z 574.2858; found: 574.2860.
Anal. Calcd for C40H35N3O.1/4CHCl3: C, 80.10; H, 5.89; N, 6.96.
Found: C, 80.17; H, 5.89; N, 7.01.
9,13,14,18-Tetraethyl-8,19-dimethyl-2-oxynaphthiporphyrin
(23a). Tripyrrane dicarboxylic acid 13a24,25 (100.2 mg) was stirred
with TFA (1 mL) under an atmosphere of nitrogen for 5 min. The
solution was diluted with dichloromethane (19 mL), followed
immediately by the addition of 4-methoxynaphthalene-1,3-dicarbal-
dehyde (22; 44.5 mg), and the mixture was stirred under nitrogen, in
the dark, for a further 3 h. After neutralization by the dropwise
addition of triethylamine, DDQ (51 mg) was added and the resulting
solution was stirred in the dark for an additional 1 h. The mixture was
washed with water and chromatographed on grade 3 neutral alumina,
eluting first with dichloromethane and then with chloroform. A deep
green fraction was collected with chloroform and recrystallized from
chloroformꢀmethanol to give the porphyrin analogue (39.4 mg;
35%) as sparkling purple needles, mp 283ꢀ284 °C; IR (KBr): ν 3343
(w, NH str.), 1630 cmꢀ1 (s, CdO str.); UVꢀvis (CHCl3): λmax (log
ε) 404 (infl, 4.68), 429 (5.30), 447 (4.94), 537 (4.01), 579 (4.49), 619
(4.14), 683 nm (3.67); UVꢀvis (20 equiv TFA-CHCl3): λmax (log ε)
406 (infl, 4.65), 431 (5.31), 460 (4.97), 550 (sh, 4.01), 571 (sh, 4.08),
596 (4.36), 614 (4.38), 667 nm (3.75); UVꢀvis (50% TFA-CHCl3):
λmax (log ε) 331 (4.54), 368 (4.68), 441 (4.79), 460 (4.79), 635
(4.47), 689 (4.08), 760 nm (3.99); 1H NMR (400 MHz, CDCl3): δ
ꢀ7.42 (1H, s), 1.69 (3H, t, J = 7.6 Hz), 1.74ꢀ1.80 (9H, 3 overlapping
triplets), 3.40 (3H, s), 3.57 (3H, s), 3.74ꢀ3.81 (4H, 2 overlapping
quartets), 3.84 (2H, q, J = 7.6 Hz), 3.93 (2H, q, J = 7.7 Hz), 7.73 (1H,
3
4
t, J = 7.5 Hz), 7.96ꢀ8.00 (1H, m), 8.92 (1H, dd, J = 7.6 Hz, J =
1.4 Hz), 8.96 (1H, d, J = 8.1 Hz), 9.27 (1H, s), 9.33 (1H, s), 9.94 (1H,
s), 10.65 (1H, s); 1H NMR (400 MHz, 1 drop TFA-CDCl3;
monocation): δ ꢀ5.69 (1H, s), ꢀ4.41 (1H, br s), ꢀ1.42 (1H, br s),
ꢀ0.98 (1H, br s), 1.54ꢀ1.60 (6H, 2 overlapping triplets), 1.78ꢀ1.85
(6H, 2 overlapping triplets), 3.46 (3H, s), 3.47 (3H, s), 3.89ꢀ4.01
(8H, m), 7.76 (1H, t, J = 7.6 Hz), 8.04ꢀ8.08 (1H, m), 8.82 (1H, d, J =
7.8 Hz), 8.94 (1H, d, J = 8.0 Hz), 9.71 (1H, s), 9.78 (1H, s), 10.55
(1H, s), 10.86 (1H, s); 13C NMR (CDCl3): δ 11.8, 11.9, 17.2, 18.4,
19.5, 19.6, 19.9, 94.2, 94.6, 103.0, 113.6, 120.1, 123.0, 124.9, 127.7,
[9,18-Diethyl-8,19-dimethyl-13,14-diphenyl-2-oxybenzipor-
phyrinato]silver(III) (26b). A suspension of silver(I) acetate (40 mg) in
methanol (10 mL) was added to a solution of 17b (20.0 mg) in chloroform
(20 mL) and the resulting mixture stirred at room temperature for 16 h. The
mixture was washed with water and evaporated under reduced pressure.
The residue was purified by column chromatography on grade 3 alumina,
5648
dx.doi.org/10.1021/jo200622s |J. Org. Chem. 2011, 76, 5636–5651